BMEA vs HUM · $94.7M cap vs P/E 39, rev $117.76B
Biomea Fusion Inc (BMEA) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
BMEA does not have a complete income-statement cache yet.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
BMEA currently screens at market cap $94.7M. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the BMEA and HUM stock pages for the full models.
Not investment advice.